Said Paul Schmelzer malegra-fair-testimonials.html.

‘development of advanced medical imaging technology is a high-tech specialty for academic and industrial groups in southeastern Wisconsin, ‘said Paul Schmelzer, prism chief executive officer. ‘this area is a breeding ground for this type of advanced technology due to the concentration of science and business expertise in medical imaging in the greater Milwaukee malegra-fair-testimonials.html malegra-dxt.org . ‘Building on this expertise have Froedtert Hospital and The Medical College of Wisconsin into a center for the development and dissemination of advanced medical facilities for the residents of Milwaukee and the upper Midwest, ‘added Schmelzer.

And Prism Medical College of Wisconsin investigators receive $ 1.6 million NIH Grant to Advanced Medical Imaging tools to developPrism Clinical Imaging, in collaboration with investigators at the Medical College of Wisconsin in Milwaukee, received a $ 1.6 million, three to grant from the National grant from the National Institutes of Health and validate clinically advanced medical imaging software, which helps in the diagnosis and treatment of patients with brain tumors. This project will enable us to refine and validate new methods for mapping brain function with MRI and for displaying the results in an intuitive format that greatly simplifies interpretation by the physician, said Edgar DeYoe, principal investigator, professor of radiology at the Medical School and co-founder of the company. Stack , similar to playing cards in a deck by Prism, we have a software that anatomical, functional anatomical, functional and physiological image sequences in a single integrated view, as a developed We have also created a new display a functional. Field map, treatment planning,ely shows what the brain images mean for the patient’s vision and movement skills. This allows the surgeon to identify and to avoid areas of the brain. Essential for the movement, the vision, and other functions, thereby removing much of the tumor as possible without deterioration of a patient’s brain function .

Our large product range development capabilities played an important role in easing of this successful Drug Application, with the goal providing much needed relief for those who are have chronic pain, commented Bookmark HN Corrigan, in the United States CombinatoRx. We will continue to on our strong D capabilities valid on the highly promising product candidates in the pipeline for the future. . Feedback and comments coordination of efforts to security of producing certainly.

Other entries from category "treatments":

Random entries